Trials / Completed
CompletedNCT05213910
Study of a Management Strategy of Functional Bowel Disordes Related to Irritable Bowel Syndrome (IBS) With a Mixture of 8 Microbiotic Strains
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 189 (actual)
- Sponsor
- PiLeJe · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to determine the impact of a 10-day treatment with Lactichoc® on irritable bowel syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lactichoc | dosage form: mix of 8 strains containing 1.2x10\^11 CFU frequency, and duration: 2 capsules/day during 10 days |
| OTHER | Stool sampling | 3 stool samples are taken during the study (D0, D10 and D30) |
Timeline
- Start date
- 2018-09-04
- Primary completion
- 2021-11-15
- Completion
- 2021-11-15
- First posted
- 2022-01-28
- Last updated
- 2022-04-06
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05213910. Inclusion in this directory is not an endorsement.